The Migraine Drugs Market continues to demonstrate robust expansion as acute migraine therapies, preventive treatments, and emerging disease-modifying approaches address the diverse clinical needs of migraine subpopulations. With many patients experiencing inadequate response to traditional triptans and non-steroidal anti-inflammatory drugs, the demand for novel acute and preventive options is...